PRESS RELEASE published on 03/20/2024 at 14:00, 1 year ago Celanese and Secarna Pharmaceuticals Enter into RNA Research Collaboration for Long-Acting Antisense Therapies Celanese and Secarna Pharmaceuticals collaborate on long-acting antisense therapy implants utilizing ASOs to target specific diseases for improved patient outcomes Celanese Secarna Pharmaceuticals Drug Delivery Antisense Therapy ASOs
PRESS RELEASE published on 11/03/2023 at 18:05, 1 year 5 months ago Secarna Pharmaceuticals presents data at SITC demonstrating the potential of antisense oligonucleotides in targeting NRP1
PRESS RELEASE published on 10/25/2023 at 15:00, 1 year 5 months ago Secarna Pharmaceuticals presents data at OTS showcasing unique characteristics and factors with a role in the activity and side effect profile of LNA-modified ASOs
PRESS RELEASE published on 10/17/2023 at 14:00, 1 year 5 months ago Secarna Pharmaceuticals to present two posters showcasing the innovation potential of the LNAplus platform at the 19th Annual Meeting of the Oligonucleotide Therapeutic Society
PRESS RELEASE published on 07/06/2023 at 14:00, 1 year 9 months ago Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in debilitating autoinflammatory diseases
PRESS RELEASE published on 06/05/2023 at 14:00, 1 year 10 months ago Secarna Pharmaceuticals announces publication of new preclinical data showing durable antitumor activity of LNAplus™-based ASOs that both stimulate the innate immune system and suppress PD-L1 expressi
PRESS RELEASE published on 03/27/2023 at 16:04, 2 years ago Secarna Pharmaceuticals and SciNeuro Pharmaceuticals enter into research and option agreement in the field of CNS diseases
Published on 04/14/2025 at 13:00, 23 minutes ago Honey Badger Silver Appoints Williams Executive Chairman and Interim CEO
Published on 04/14/2025 at 13:00, 23 minutes ago Lobe Sciences Ltd. Announces Private Placement to Support Drug Development of Novel Conjugated Psilocin(TM)
Published on 04/14/2025 at 13:00, 23 minutes ago NioCorp CEO Mark Smith to Appear on Fox Business Network’s "Mornings with Maria" Show on Wednesday, April 16
Published on 04/14/2025 at 12:30, 53 minutes ago Ascendant Resources Notifies Shareholders Of Upcoming Special Meeting
Published on 04/14/2025 at 13:09, 14 minutes ago Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): Kaufen
Published on 04/14/2025 at 11:51, 1 hour 32 minutes ago Dalata Hotel Group PLC: HOL-Holding(s) in Company*
Published on 04/14/2025 at 11:45, 1 hour 38 minutes ago Senkron Digital Debuts at WindEurope 2025 with Bold Brand and Transformative Solutions
Published on 04/14/2025 at 11:31, 1 hour 52 minutes ago Mise à disposition du Document d’Enregistrement Universel 2024
Published on 04/14/2025 at 08:15, 5 hours 8 minutes ago Aéroports de Paris SA - Filing of the 2024 Universal Registration Document
Published on 04/14/2025 at 08:15, 5 hours 8 minutes ago Aéroports de Paris SA - Mise à disposition du document d'enregistrement universel 2024
Published on 04/11/2025 at 18:30, 2 days 18 hours ago Reclassification of shares within the Feuillet family concert with no impact on the control of the company
Published on 04/11/2025 at 18:30, 2 days 18 hours ago Reclassement d'actions au sein du concert familial Feuillet sans incidence sur le contrôle de la société
